HomeCompareCTKYY vs MRK

CTKYY vs MRK: Dividend Comparison 2026

CTKYY yields 7380.07% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTKYY wins by $2782548293338877.00M in total portfolio value
10 years
CTKYY
CTKYY
● Live price
7380.07%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2782548293338877.00M
Annual income
$2,710,305,372,256,298,600,000.00
Full CTKYY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CTKYY vs MRK

📍 CTKYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTKYYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTKYY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTKYY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTKYY
Annual income on $10K today (after 15% tax)
$627,306.27/yr
After 10yr DRIP, annual income (after tax)
$2,303,759,566,417,853,700,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CTKYY beats the other by $2,303,759,566,417,853,700,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTKYY + MRK for your $10,000?

CTKYY: 50%MRK: 50%
100% MRK50/50100% CTKYY
Portfolio after 10yr
$1391274146669438.50M
Annual income
$1,355,152,686,128,149,300,000.00/yr
Blended yield
97.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CTKYY
No analyst data
Altman Z
-1.2
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTKYY buys
0
MRK buys
0
No recent congressional trades found for CTKYY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTKYYMRK
Forward yield7380.07%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2782548293338877.00M$56.8K
Annual income after 10y$2,710,305,372,256,298,600,000.00$9,798.13
Total dividends collected$2777712434242760.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CTKYY vs MRK ($10,000, DRIP)

YearCTKYY PortfolioCTKYY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$748,707$738,007.38$11,206$366.19+$737.5KCTKYY
2$52,441,451$51,640,333.83$12,650$502.35+$52.43MCTKYY
3$3,436,510,436$3,380,398,083.68$14,407$694.19+$3436.50MCTKYY
4$210,704,089,989$207,027,023,822.12$16,585$967.82+$210704.07MCTKYY
5$12,088,563,443,530$11,863,110,067,242.08$19,342$1,363.89+$12088563.42MCTKYY
6$649,021,749,235,005$636,086,986,350,428.00$22,913$1,947.19+$649021749.21MCTKYY
7$32,611,102,400,134,300$31,916,649,128,452,844.00$27,662$2,823.89+$32611102400.11MCTKYY
8$1,533,680,270,878,520,000$1,498,786,391,310,376,200.00$34,159$4,173.35+$1533680270878.49MCTKYY
9$67,516,748,675,306,635,000$65,875,710,785,466,630,000.00$43,337$6,308.80+$67516748675306.59MCTKYY
10$2,782,548,293,338,877,000,000$2,710,305,372,256,298,600,000.00$56,776$9,798.13+$2782548293338877.00MCTKYY

CTKYY vs MRK: Complete Analysis 2026

CTKYYStock

CooTek (Cayman) Inc. operates as a mobile internet company in the United States, the People's Republic of China, and internationally. The company offers Fengdu Novel, a mobile application that provides users with free online novels; and Fengdu Literature, a platform covering 14 major categories of male and female preferred content, including genres of romance, fantasy, science fiction, history, and others. It also provides casual games, such as dress-up games, including Catwalk Beauty, Truth Runner, and Love Fantasy; simulation games comprising Farm Hero and Idle Land King Tycoon; puzzle games, such as Hi Hamster; and educational games consisting of Puzzle No. 1 and Idiom Hero. In addition, the company offers TouchPal Smart Input, an input method for mobile devices that supports approximately 110 languages and available on both Android and iOS operating systems. It distributes its products and acquires users primarily through user downloads from digital distribution platforms and social media. The company was founded in 2008 and is headquartered in Shanghai, the People's Republic of China.

Full CTKYY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CTKYY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTKYY vs SCHDCTKYY vs JEPICTKYY vs OCTKYY vs KOCTKYY vs MAINCTKYY vs JNJCTKYY vs ABBVCTKYY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.